7682-20-4,
(S)-2-Aminobutyramide hydrochloride,
(S)-2-Aminobutanamide hydrochloride,
h-abu-nh2 hcl,
(2S)-2-aminobutanamide Hydrochloride,
L-2-Aminobutanamide hydrochloride,
l-homoalanylamide hcl,
(S)-(+)-2-Aminobutanamide hydrochloride,
(S)-2-Aminobutanamide HCl,
(s)-2-amino butanamide hcl,
(s)-2-amino-butanamide hcl,
Butanamide, 2-amino-, monohydrochloride, (2S)-,
(S)-2-Aminobutanamidehydrochloride,
MFCD00136565,
Q-102786,
h-abu(2)-nh2 hcl,
(s)-2-amino-butylactamide,
AK-49090,
(2S)-2-aminobutanamide;hydrochloride,
(S)-2-amino-butanamide hydrochloride,
s (+)-2-aminobutyramide hydrochloride,
H-Abu-NH2Cl,
l-2-aminobutanamide hcl,
L-2-Aminobutanamide, HCl,
KSC490I4J,
SCHEMBL373444,
L-Homoalanylamide hydrochloride,
(s)-2-amino-butylactamide hcl,
CTK3J0444,
KS-00000AAV,
DTXSID10474839,
HDBMIDJFXOYCGK-DFWYDOINSA-N,
ACT02761,
CS-B0864,
ANW-36890,
CH-233,
H-Abu-NH2 hydrochloride, AldrichCPR,
AKOS015910759,
DS-1209,
OR46608,
RP20491,
RTR-024583,
AC-23986,
BC209264,
BR-49090,
N758,
SC-15825,
AB0016018,
AX8022555,
TL8005266,
AM20100759,
FT-0636564,
ST24032105,
M-3341,
(S)-(+)-2-Aminobutanamide hydrochloride, 97%,
682A204,
(2S)-2-Aminobutanamide--hydrogen chloride (1/1),
I14-40142,
I14-44373,
Levetiracetam Related Compound B, United States Pharmacopeia (USP) Reference Standard,
L-2-Aminobutanamide,
(2S)-2-aminobutyramide,
C4H11ClN2O,
S-AMINO BUTANAMIDE Hydrochloride,
2-Aminobutyric acid amide hydrochloride,
ACN-043383,
CS-O-32309,
CID11961924,
A2252,
(S)-( )-2-Amino butylactamide hydrochloride, 98% - 1G 1g,
141978-61-2,